Emerging evidence has demonstrated the neuroprotective effects of niacin in Parkinson's disease, Alzheimer's disease, and ischemic stroke, primarily through HCAR2 activation [12,14,31]. The gene discussed is HCAR2; the disease is early-onset autosomal dominant Alzheimer disease.